KISSEI PHARMACEUTICAL CO (4547.T) Financials
4547.T Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 257.9 billion | 37.0 billion |
| March 31, 2024 | 260.9 billion | 39.8 billion |
| Dec. 31, 2023 | 228.5 billion | 30.9 billion |
| Sept. 30, 2023 | 231.9 billion | 30.3 billion |
4547.T Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | ? | ? |
| March 31, 2024 | ? | ? |
| Dec. 31, 2023 | 2.1 billion | ? |
| Sept. 30, 2023 | 2.1 billion | ? |
4547.T Net Income
| Date | Net Income |
|---|---|
| June 30, 2024 | ? |
| March 31, 2024 | 2.8 billion |
| Dec. 31, 2023 | 2.7 billion |
| Sept. 30, 2023 | 2.4 billion |
4547.T Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 45.9 billion | - | - |
| March 31, 2024 | 45.9 billion | - | 236.0 million |
| Dec. 31, 2023 | 43.2 billion | - | 624.0 million |
| Sept. 30, 2023 | 47.5 billion | - | 616.0 million |
4547.T Shares Outstanding
4547.T Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | - | - | 8.7 billion | - |
| March 31, 2024 | - | 2.7 billion | 6.2 billion | - |
| Dec. 31, 2023 | - | 2.3 billion | 5.9 billion | - |
| Sept. 30, 2023 | - | 2.3 billion | 6.0 billion | - |
4547.T Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 21.2 billion | 10.3 billion |
| March 31, 2024 | 17.7 billion | 8.9 billion |
| Dec. 31, 2023 | 20.9 billion | 10.6 billion |
| Sept. 30, 2023 | 17.7 billion | 8.9 billion |
4547.T
Price: ¥3,475
Dividend Yield: 0.02%
Forward Dividend Yield: 2.59%
Payout Ratio: 30.53%
Dividend Per Share: 90.00 JPY
Earnings Per Share: 268.62 JPY
P/E Ratio: 12.94
Exchange: JPX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 153.6 billion
Average Dividend Frequency: 2
Years Paying Dividends: 24
DGR3: 16.31%
DGR5: 11.32%
DGR10: 7.89%
DGR20: 11.79%